Search Results - "Lees, C.W."

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease by Rahier, J.F., Magro, F., Abreu, C., Armuzzi, A., Ben-Horin, S., Chowers, Y., Cottone, M., de Ridder, L., Doherty, G., Ehehalt, R., Esteve, M., Katsanos, K., Lees, C.W., MacMahon, E., Moreels, T., Reinisch, W., Tilg, H., Tremblay, L., Veereman-Wauters, G., Viget, N., Yazdanpanah, Y., Eliakim, R., Colombel, J.F.

Get full text

W09-03 - Associations of affective disorder in patients with inflammatory bowel disease by Baig, B.J, Lees, C.W, Johnstone, E.C, James, V, Satsangi, J, Lawrie, S.M

“…Introduction Inflammatory Bowel Disease (IBD) is associated with co morbid depression and anxiety of up to 42%. Corticosteroids, used commonly in IBD, are…”
Get full text

8 Characterization of the ∼40,000 patient cohort of the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) by Lees, C.W.

Get full text

P586 A novel approach to the implementation of biosimilar infliximab CT-P13 for the treatment of IBD utilising therapeutic drug monitoring: the Edinburgh experience by Plevris, N., Deekae, A., Jones, G.R., Manship, T.A., Noble, C.L., Satsangi, J., Shand, A.G., Arnott, I.D., Lees, C.W.

Get full text

P416 Real world data on the effectiveness and safety of vedolizumab in the treatment of Crohn's disease and ulcerative colitis: the Edinburgh experience by Plevris, N., Manship, T.A., Deekae, A., Jones, G.R., Noble, C.L., Satsangi, J., Shand, A.G., Arnott, I.D., Lees, C.W.

Get full text

Lack of association between cervical dysplasia and IBD: A large case–control study by Lees, C.W., Critchley, J., Chee, N., Beez, T., Gailer, R.E., Williams, A.R., Shand, A.G., Arnott, I.D.R., Satsangi, J.

“…Background: It has been variously reported that women with inflammatory bowel disease (IBD) have an increased risk of cervical dysplasia. We aimed to assess in…”
Get full text

P220 Faecal calprotectin and ileal Crohn's disease: correlation with a small bowel MRI score for disease activity by Fascì-Spurio, F., Kennedy, N.A., Wong, L., MacLean, P., Satsangi, J., Glancy, S., Lees, C.W.

Get full text

P349 Serum calprotectin: a novel biomarker to predict outcome in acute severe ulcerative colitis? by Hare, N.C., Kennedy, N.A., Kalla, R., Kingstone, K., Arnott, I.D.R., Shand, A.G., Palmer, K., Penman, I., Lees, C.W., Satsangi, J.

Get full text

Associations of affective disorder in patients with inflammatory bowel disease by Baig, B.J., Lees, C.W., Johnstone, E.C., James, V., Satsangi, J., Lawrie, S.M.

“…Introduction Inflammatory Bowel Disease (IBD) is associated with co morbid depression and anxiety of up to 42%. Corticosteroids, used commonly in IBD, are…”
Get full text

P705 Evaluation of the impact of different commercially available DNA extraction kits and laboratories for assessing bacterial community structure in fecal samples – implications for IBD research by Kennedy, N.A., Walker, A.W., Berry, S.H., Duncan, S.H., Farquarson, F., Louis, P., Satsangi, J., Flint, H.J., Lees, C.W., Hold, G.L.

Get full text

P266 Correlation of clinical symptoms to current biomarkers of intestinal inflammation in patients with Crohn's disease by Chang, J., Kennedy, N., Fascí Spurio, F., Muscat, M., Guy, M., Satsangi, J., Arnott, I., Kingstone, K., Lees, C.W.

Get full text

Magnetic resonance follow‐through imaging for evaluation of disease activity in ileal Crohn's disease: An observational, retrospective cohort study by Parisinos, C.A., McIntyre, V.E.D., Heron, T., Subedi, D., Arnott, I.D.R., Mowat, C., Wilson, D.C., McGurk, S., Glancy, S., Zealley, I.A., Satsangi, J., Lees, C.W.

“…Background: Magnetic resonance follow‐through (MRFT) is a new cross‐sectional imaging modality with the potential to accurately stage ileal Crohn's disease…”
Get full text

P250 Elevated faecal calprotectin predicts disease progression in Crohn's disease by Kennedy, N.A., Chang, J., Guy, M.H., Smith, T., Loh, J.T., Haunschmidt, D., Muscat, M., Fascí Spurio, F., Drummond, H.E., Kingstone, K., Noble, C.L., Shand, A.G., Satsangi, J., Arnott, I.D., Lees, C.W.

Get full text

Contribution of the NOD1/CARD4 insertion/deletion polymorphism +32656 to inflammatory bowel disease in Northern Europe by Van Limbergen, J., Russell, R.K., Nimmo, E.R., Törkvist, L., Lees, C.W., Drummond, H.E., Smith, L., Anderson, N.H., Gillett, P.M., McGrogan, P., Hassan, K., Weaver, L.T., Bisset, W.M., Mahdi, G., Arnott, I.D., Sjöqvist, U., Lördal, M., Farrington, S.M., Dunlop, M.G., Wilson, D.C., Satsangi, J.

“…Background: NOD1/CARD4 and NOD2/CARD15 are both intracellular pattern‐recognition receptors. The NOD1/CARD4 gene lies within a previously described…”
Get full text

O05 IDENTIFICATION OF GLI-1 AS AN IBD2 SUSCEPTIBILITY GENE by Lees, C.W., Nimmo, E., Tenesa, A., Campbell, H., Howie, S.E.M., Dunlop, M.G., Satsangi, J.

Get full text

P150 PREGNANCY OUTCOME AND FERTILITY IN INFLAMMATORY BOWEL DISEASE IS INFLUENCED BY DISEASE PHENOTYPE by Lees, C.W., Gailer, R.E., Johnston, N.C., Warner, P., Critchley, H.O., Satsangi, J.

Get full text

P118 INFLIXIMAB AS RESCUE THERAPY IN ACUTE SEVERE UC: A SURVEY OF THE SCOTTISH SOCIETY OF GASTROENTEROLOGY (SSG) by Lees, C.W., Heys, D., Shand, A.G., Penman, I.D., Palmer, K.R., Noble, C.L., Mowat, C., Jafferbhoy, H., Boulton-Jones, R., Williams, A., Gillett, H., Evans, C., Todd, J., Church, N., Vaidya, K.

Get full text